Picture of Personalis logo

PSNL — Personalis News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Personalis Inc reports results for the quarter ended December 31 - Earnings Summary

Personalis Inc PSNL.OQ reported a quarterly adjusted loss of 23 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -54 cents.  The mean expectation of six analysts for the quarter was for a loss of 28 cents per share. Wall Street expected results to range from -34 cents to -21 cents per share.

Revenue fell 14.6% to $16.80 million from a year ago; analysts expected $15.74 million.

Personalis Inc's reported EPS for the quarter was a loss of 23 cents​.

The company reported a quarterly loss of $16.43 million.

Personalis Inc shares had fallen by 22.5% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 6% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Personalis Inc is $8.00

This summary was machine generated from LSEG data February 27 at 10:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Dec. 31 2024-0.28-0.23Beat
Sep. 30 2024-0.35-0.64Missed
Jun. 30 2024-0.37-0.24Beat
Mar. 31 2024-0.41-0.26Beat

Recent news on Personalis

See all news